Position in JNJ
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$7,711,545
-$864,387 QoQ
Shares Held
30,364
-13.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#1,277
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CX Institutional holds $115,444,232 across 15 Drug Manufacturers - General names. JNJ ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,493 | $42,571,372 | |
| 2 | ABBV |
AbbVie Inc.
|
78,286 | $19,699,889 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
263,596 | $15,188,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
95,317 | $12,248,234 | |
| 5 | AMGN |
Amgen Inc
|
25,985 | $9,409,688 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
30,364 | $7,711,545 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,297 | $7,365,242 | |
| 8 | PFE |
Pfizer Inc
|
27,825 | $670,026 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,711,545 | 30,364 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $8,575,932 | 35,084 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $13,541,773 | 65,435 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $12,841,632 | 69,257 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $9,790,053 | 64,092 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $10,304,302 | 62,134 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $8,433,226 | 58,313 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $7,968,004 | 49,167 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $5,307,215 | 36,311 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $6,328,232 | 40,004 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $5,434,332 | 34,671 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $5,396,270 | 34,647 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $3,385,711 | 20,455 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $2,952,750 | 19,050 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $3,230,398 | 18,287 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,892,125 | 17,704 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $5,207,610 | 29,337 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,139,138 | 28,997 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,435,064 | 31,771 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $5,891,197 | 36,478 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,866,061 | 35,608 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $5,900,822 | 35,904 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $5,578,491 | 35,446 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $5,343,600 | 35,892 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,028,447 | 14,424 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,738,390 | 13,257 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||